Abstract
Brain cancers, such as Glioblastoma Multiforme (GBM), exploit the bodys own immune system to support tumor growth within their microenvironment. GBM, an incurable cancer known for its highly invasive characteristics, utilizes various pro-inflammatory pathways to mediate the bodys response, one of them being the CCR5 signaling pathway.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
